Most automakers’ Q2 sales in the U.S. didn’t fare well, and of the three that did experience gains, one stood out ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Kai Mao, an exterior designer at Dongfeng Design, also doubles in his free time as the virtual artist behind the 'kaiser.mao' ...

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.

Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...

President Trump on Wednesday said he would be sending letters to over 150 countries as he plans a barrage of duties to take ...